Epoxyeicosatrienoic acids regulate Trp channel-dependent Ca2+ signaling and hyperpolarization in endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 27, Issue 12, 2007, Pages 2612-2618

  Fleming, Ingrid ^a   Rueben, Alexandra ^a   Popp, Rüdiger ^a   Fisslthaler, Beate ^a   Schrodt, Susanne ^a   Sander, Anna ^a   Haendeler, Judith ^a   Falck, John R ^b   Morisseau, Christophe ^c   Hammock, Bruce D ^c   Busse, Rudi ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Caveolae; Cytochrome P450; Endothelium derived hyperpolarizing factor; Protein kinase A

Indexed keywords

1 ADAMANTYL 3 CYCLOHEXYLUREA; APAMIN; BRADYKININ; CHARYBDOTOXIN; CYCLIC AMP; CYTOCHROME P450; CYTOCHROME P450 2C9; EPOXIDE HYDROLASE; EPOXYICOSATRIENOIC ACID; POTASSIUM CHANNEL; RUTHENIUM RED; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL MEMBRANE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPERPOLARIZATION; PRIORITY JOURNAL;

8,11,14-EICOSATRIENOIC ACID; ADAMANTANE; APAMIN; BIOLOGICAL FACTORS; BRADYKININ; CALCIUM SIGNALING; CAVEOLIN 1; CELL MEMBRANE; CELLS, CULTURED; CHARYBDOTOXIN; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOCHROME P-450 ENZYME SYSTEM; EICOSANOIC ACIDS; ENDOTHELIAL CELLS; ENZYME INHIBITORS; EPOXIDE HYDROLASES; HUMANS; MEMBRANE POTENTIALS; MEMBRANE TRANSPORT MODULATORS; MICONAZOLE; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; RUTHENIUM RED; THIONUCLEOTIDES; TIME FACTORS; TRANSFECTION; TRPC CATION CHANNELS; VASODILATOR AGENTS;

EID: 36348997094     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.107.152074     Document Type: Article

References (31)

1. Michaelis UR, Fleming I. From endothelium-derived hyperpolarizing factor (EDHF) to angiogenesis: epoxyeicosatrienoic acids (EETs) and cell signaling. Pharmacol Ther. 2006;111:584-595.
2. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res. 1996;78:415-423.
3. Zygmunt PM, Högestätt ED. Role of potassium channels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery. Br J Pharmacol. 1996;117:1600-1606.
4. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 1999;401:493-497.
5. Weston AH, Feletou M, Vanhoutte PM, Falck JR, Campbell WB, Edwards G. Bradykinin-induced, endothelium-dependent responses in porcine coronary arteries: involvement of potassium channel activation and epoxyeicosatrienoic acids. Br J Pharmacol. 2005;145:775-784.
6. Imig JD, Inscho EW, Deichamnn PC, Reddy KM, Falck JR. Afferent arteriolar vasodilation to the sulfonimide analog of 11,12-epoxyeicosatrienoic acid involves protein kinase A. Hypertension. 1999;33:408-413.
7. 2+ entry in porcine aortic endothelial cells. Br J Pharmacol. 1997;121:1579-1588.
8. Newman JW, Morisseau C, Hammock BD. Epoxide hydrolases: their roles and interactions with lipid metabolism. Prog Lipid Res. 2005;44:1-51.
9. Morisseau C, Goodrow MH, Newman JW, Wheelock CE, Dowdy DL, Hammock BD. Structural refinement of inhibitors of urea-based soluble epoxide hydrolases. Biochem Pharmacol. 2002;63:1599-1608.
10. Gauthier KM, Deeter C, Krishna UM, Reddy YK, Bondlela M, Falck JR, Campbell WB. 14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries. Circ Res. 2002;90:1028-1036.
11. Morisseau C, Newman JW, Dowdy DL, Goodrow MH, Hammock BD. Inhibition of microsomal epoxide hydrolases by ureas, amides, and amines. Chem Res Toxicol. 2001;14:409-415.
12. Busse R, Lamontagne D. Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells. Naunyn Schmiedebergs Arch Pharmacol. 1991;344:126-129.
13. Michaelis UR, Falck JR, Schmidt R, Busse R, Fleming I. Cytochrome P4502C9-derived epoxyeicosatrienoic acids induce the expression of cyclooxygenase-2 in endothelial cells. Arterioscler Thromb Vasc Biol. 2005;25:321-326.
14. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A. 1998;95:2509-2514.
15. Randriamboavonjy V, Busse R, Fleming I. 20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase. Hypertension. 2003;41:801-806.
16. Fleming I, Fisslthaler B, Dixit M, Busse R. Role of PECAM-1 in the shear-stress-induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells. J Cell Sci. 2005;118:4103-4111.
17. Popp R, Fleming I, Busse R. Pulsatile stretch in coronary arteries elicits release of endothelium-derived hyperpolarizing factor: a modulator of arterial compliance. Circ Res. 1998;82:696-703.
18. Mancy A, Dijols S, Poli S, Guengerich P, Mansuy D. Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9. Biochemistry. 1996;35:16205-16212.
19. Wong PY, Lai PS, Shen SY, Belosludtsev YY, Falck JR. Post-receptor signal transduction and regulation of 14(R),15(S)-epoxyeicosatrienoic acid (14,15-EET) binding in U-937 cells. J Lipid Mediat Cell Signal. 1997;16:155-169.
20. +-channel activity. Am J Physiol Renal Physiol. 1996;270:F822-F832.
21. + channels by epoxyeicosatrienoic acids in rat cardiac ventricular myocytes. J Physiol (Lond). 2001;537:811-827.
22. Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature. 2003;424:434-438.
23. Bezzerides VJ, Ramsey IS, Kotecha S, Greka A, Clapham DE. Rapid vesicular translocation and insertion of TRP channels. Nat Cell Biol. 2004;6:709-720.
24. Gias UA, Asrar BM. Functional role of TRPC channels in the regulation of endothelial permeability. Pflügers Archiv Eur J Physiol. 2005;451:131-142.
25. 2+ entry in human and bovine endothelial cells. J Physiol (Lond). 1995;482:259-274.
26. 2+ permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium. Circ Res. 2005;97:908-915.
27. Clapham DE. TRP channels as cellular sensors. Nature. 2003;426:517-524.
28. 2+ entry: role in signaling increased endothelial permeability. J Biol Chem. 2003;278:33492-33500.
29. Gauthier KM, Edwards EM, Falck JR, Reddy DS, Campbell WB. 14,15-Epoxyeicosatrienoic acid represents a transferable endothelium-dependent relaxing factor in bovine coronary arteries. Hypertension. 2005;45:666-671.
30. Yu Z, Xu F, Huse LM, Morisseau C, Draper AJ, Newman JW, Parker C, Graham L, Engler MM, Hammock BD, Zeldin DC, Kroetz DL. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ Res. 2000;87:992-998.
31. Jung O, Brandes RP, Kim IH, Schweda F, Schmidt R, Hammock BD, Busse R, Fleming I. Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension. Hypertension. 2005;45:759-765.